Stay at the forefront of Boston’s technology and digital health advancements as biopharma, investment, and government come together to drive life sciences
As the nation’s largest biopharma cluster, Boston has a proven track record of life science leadership, including emerging therapeutics. Digital technologies will play a critical role in the expansion of this industry poised to grow more than $350 billion in the next five years. Great progress has been made, but significant scientific, technological, financial, and regulatory challenges remain. We’ll take a closer look at what’s been accomplished and address how to handle the hurdles that lie ahead.